Innovative ICR-discovered drug to enter first clinical trial, targeting HSF1 pathway 26 Aug 2021 Cancer patients are set to receive, for the first time, a highly innovative investigational drug called NXP800 – which was discovered at The Institute of Cancer Research, London. Find out more Show/Hide